Haplotypes across the human caveolin 1 gene upstream purine complex significantly alter gene expression: Implication in neurodegenerative disorders

Gene

Volumn 505, Issue 1, 2012, Pages 186-189

  Heidari, A ^a   Hosseinkhani, S ^b   Talebi, S ^c   Meshkani, R ^d   Esmaeilzadeh Gharedaghi, E ^a   Banan, M ^a   Darvish, H ^a   Ohadi, M ^a  

^a UNIVERSITY OF SOCIAL WELFARE AND REHABILITATION SCIENCES   (Iran)

^b TARBIAT MODARES UNIVERSITY   (Iran)

^c AVICENNA RESEARCH INSTITUTE   (Iran)

^d TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Caveolin 1; Expression; Neurodegenerative disorder; Purine complex; Upstream

Indexed keywords

CAVEOLIN 1; LUCIFERASE; PURINE;

ARTICLE; CELL LINE; DEMYELINATING DISEASE; ENZYME ASSAY; GENE CONSTRUCT; GENE EXPRESSION; GENETIC RISK; GENETIC SUSCEPTIBILITY; HAPLOTYPE; HOMOZYGOTE; HUMAN; HUMAN CELL; NERVE CELL; PRIORITY JOURNAL;

5' UNTRANSLATED REGIONS; ALZHEIMER DISEASE; CAVEOLIN 1; CELL LINE, TUMOR; GENE EXPRESSION REGULATION; HAPLOTYPES; HOMOZYGOTE; HUMANS; MULTIPLE SCLEROSIS; PROTO-ONCOGENE PROTEINS C-ETS;

EID: 84863880116     PISSN: 03781119     EISSN: 18790038     Source Type: Journal    
DOI: 10.1016/j.gene.2012.05.018     Document Type: Article

References (24)

1. Block M., Hong J.S. Microglia and inflammation-mediated neurodegenertion: multiple triggers with a common mechanism. Prog Neurobiol. 2005, 76(2):77-98. (Review).
2. Businaro R., et al. S100B protects LAN-5 neuroblastoma cells against Abeta amyloid-induced neurotoxicity via RAGE engagement at low doses but increases Abeta amyloid neurotoxicity at high doses. J. Neurosci. Res. 2006, 83(5):897-906. (Apr).
3. Chakrabarty P., et al. Interferon-γ induces progressive nigrostriatal degeneration and basal ganglia calcification. Nat. Neurosci. 2011, 14:694-696.
4. Chiarini A., Whitfield J., Bonafini C., Chakravarthy B., Arnato U., Dal Pra I. Amyloid-β(25-35), an amyloid-β(1-42) surrogate, and proinflammatory cytokines stimulate VEGF-A secretion by cultured, early passage, normoxic adult human cerebral astrocytes. J Alzheimer's Dis. 2010, 21(3):915-926.
5. Darvish H., et al. Exceptional human core promoter nucleotide compositions. Gene 2011, 475:79-86.
6. Gaudreault S.B., Dea D., Poirier J. Increased caveolin-1 expression in Alzheimer's disease brain. Neurobiol. Aging 2004, 25(6):753-759.
7. Glass C.K., Saijo K., Winner B., Marchetto M.C., Gage F.H. Mechanisms underlying inflammation in neurodegeneration. Cell 2010, 140:918-934. (Review).
8. Hattori C., et al. BACE1 interacts with lipid raft proteins. J. Neurosci. Res. 2006, 84:912-917.
9. Head B.P., et al. Loss of caveolin-1 accelerates neurodegeneration and aging. PLoS One 2010, 5(12):e15697. 10.1371/journal.pone.0015697.
10. Head B.P., et al. Neuron-targeted caveolin-1 enhances signaling and promotes arborization of primary neurons. J. Biol. Chem. 2011, 286:33310-33321.
11. Heidari A., et al. The human caveolin 1 gene upstream purine complex and neurodegeneration-a common signature. J. Neuroimmunol. 2011, 236(1-2):106-110.
12. Heidari A., et al. Core promoter STRs: novel mechanism for inter-individual variation in gene expression in humans. Gene 2012, 492:195-198.
13. Heshmati Y., et al. A novel polymorphic purine complex at the 1.5kb upstream region of the human caveolin-1 gene and risk of Alzheimer's disease; extra-short alleles and accumulated allele homozygosity. Am. J. Med. Genet. B Neuropsychiatr. Genet. 2009, 150B(2):248-253.
14. Kang M.J., et al. Caveolin-1 upregulation in senescent neurons alters amyloid precursor protein processing. Exp. Mol. Med. 2006, 38(2):126-133.
15. Kim H., et al. Increased phosphorylation of caveolin-1 in the spinal cord of Lewis rats with experimental autoimmune encephalomyelitis. Neurosci. Lett. 2006, 402(1-2):76-80.
16. Lev N., Ickowicz D., Barhum Y., Blondheim N., Melamed E., Offen D. Experimental encephalomyelitis induces changes in DJ-1: implications for oxidative stress in multiple sclerosis. Antioxid. Redox Signal. 2006, 11-12:1987-1995.
17. Mandel S.A., Amit T., Weinreb O., Reznichenko L., Youdim M.B. Simultaneous manipulation of multiple brain targets by green tea catechins: a potential neuroprotective strategy for Alzheimer and Parkinson diseases. CNS Neurosci. Ther. 2008, 14(4):352-365.
18. Mikol D.D., Scherer S.S., Duckett S.J., Hong H.L., Feldman E.L. Schwann cell caveolin-1 expression increases during myelination and decreases after axotomy. Glia 2002, 38(3):191-199.
19. Oka N., et al. Caveolin interaction with protein kinase c: isoenzymedependent regulation of kinase activity by the caveoli-scaffolding domain peptide. J. Biol. Chem. 1997, 272(52):33416-33421.
20. Qing H., et al. Valproic acid inhibits Abeta production, neuritic plaque formation, and behavioral deficits in Alzheimer's disease mouse models. J. Exp. Med. 2008, 205(12):2781-2789.
21. Shin T., et al. Expression of caveolin-1, -2, and -3 in the spinal cords of Lewis rats with experimental autoimmune encephalomyelitis. J. Neuroimmunol. 2005, 165(1-2):11-20.
22. Weinstock-Guttman B., et al. Serum lipid profiles are associated with disability and MRI outcomes in multiple sclerosis. J. Neuroinflammation 2011, 8:127.
23. Zarif Yeganeh M., et al. Skew in the human caveolin 1 gene upstream purine complex homozygote haplotype compartment in multiple sclerosis. J. Neuroimmunol. 2009, 216(1-2):103-107.
24. Zarif Yeganeh M., et al. Novel extreme homozygote haplotypes at the human caveolin 1 gene upstream purine complex in sporadic Alzheimer's disease. Am. J. Med. Genet. B Neuropsychiatr. Genet. 2010, 153B(1):347-349.